LNC
CVRS

Lincoln National Corp’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Lincoln National Corp’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,000
Closed -$23K – 592
2019
Q1 		$23K Hold
13,000
– – ﹤0.01% 508
2018
Q4 		$11K Buy
+13,000
New +$15.5K ﹤0.01% 474

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Lincoln National Corp's CVRS Position: Q2 2019 in Review

Lincoln National Corp sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2019, closing a stake of 13,000 shares — an estimated $23K sold.

Lincoln National Corp first reported a position in CVRS in Q4 2018 and held it in 2 quarters. The position peaked at $23K in Q1 2019. 81 funds tracked by Wall St. Rank hold CVRS as of Q2 2019.

  • Lincoln National Corp reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2019 after selling out during the quarter.
  • Lincoln National Corp sold 13,000 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2019, an estimated $23K.
  • Lincoln National Corp first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q4 2018 and held it in 2 quarters.
  • Lincoln National Corp's CORINDUS VASCULAR ROBOTICS, INC position peaked at $23K in Q1 2019.
  • 81 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2019.

Based on Lincoln National Corp's 13F filing for Q2 2019, filed 6 Aug 2019.